Neurophysiological evidence of spared upper motor conduction fibers in clinically complete spinal cord injury: Discomplete SCI in rats

Journal of the Neurological Sciences

Volumn 189, Issue 1-2, 2001, Pages 23-36

  Yu, Kewei ^a   Rong, Weifang ^b   Li, Jiashun ^a   Jia, Lianshun ^a   Yuan, Weng ^a   Yie, Xiaojian ^a   Shi, Zhichai ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

4 Aminopyridine; Discomplete spinal cord injury; Microelectrode; Motor evoked potential; Rat

Indexed keywords

4 AMINOPYRIDINE;

ANIMAL EXPERIMENT; ARTICLE; EVOKED MUSCLE RESPONSE; EXTRAPYRAMIDAL SYSTEM; MALE; MICROELECTRODE; MOTOR CORTEX; NERVE CONDUCTION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

ANIMALS; EVOKED POTENTIALS, MOTOR; HEMORRHAGE; HUMANS; MALE; MOTOR NEURONS; NECROSIS; NERVE DEGENERATION; NEURAL CONDUCTION; PARAPLEGIA; PYRAMIDAL TRACTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0035881643     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00545-7     Document Type: Article

References (30)

1. Stimulation of the cerebral cortex in the intact human subject
2. Non-invasive magnetic stimulation of human motor cortex
3. Suprasegmentally induced motor unit activity in paralyzed muscles of patients with established spinal cord injury
4. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury
5. Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases
6. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury
7. A new model of acute compressive spinal cord injury in vitro
8. Changes in pharmacological sensitivity of the spinal cord to potassium channel blockers following acute spinal cord injury
9. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord
10. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine
11. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury
12. The effect of graded spinal cord injuries on transcranial electric stimulation motor evoked potentials in the rat
13. Noncortical origins of the spinal motor evoked potential in rats
14. Motor evoked potentials from transcranial stimulation of the motor cortex in cats
15. Motor evoked potentials from transcranial stimulation of the motor cortex in humans
16. Single multiple unit analysis of cortical stage of pyramidal tract activation
17. Suprathreshold brain stimulation activates non-cortical spinal motor evoked potentials in cats
18. Origins and conducting pathways of motor evoked potentials elicited by transcranial (vertex-hard palate) simulation in cats
19. Locating corticospinal neurons by retrograde axonal transport of horseradish perioxidase
20. Motor Evoked Potentials recorded from normal and spinal cord injured rat
21. Effects of limited direct stimulation of the medullary pyramidal tract on spinal motor neurons in the rat
22. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury
23. Evidence of subclinical brain influence in clinical complete spinal cord injury: discomplete SCI
24. Demyelination in spinal cord injury
25. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury
26. Voluntary supraspinal suppression of spinal reflex activity in paralyzed muscles of spinal cord injury patients
27. Neurophysiological evidence of spared uppermotor neurons after spinal cord injury
28. Persistence of rubrospinal projections following spinal cord injury in the rat
29. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury
30. + channels after chronic spinal cord injury